New number of shares and votes in IRLAB Therapeutics AB

During July 2026, the registered number of shares and votes in IRLAB Therapeutics AB (”IRLAB” or the “Company”) has changed as a result of the Company’s recently completed rights issue and overallotment issue of ordinary shares of series A, which the Board of Directors resolved on 5 May 2026 and which were approved by the Extraordinary General Meeting on 5 June 2026.

IRLAB’s rights issue is registered – conversion of BTA into shares

Report from the Annual General Meeting 2026 of IRLAB Therapeutics AB